
Pediatrics Drugs
Prescription drugs and medicines for conditions relating to children and infants. Studies in these areas include: anorexia, asthma, Attention Deficit Hyperactivity Disorder (ADHD), birth defects, cancers in children, child depression, growth deficiencies, juvenile diabetes, obesity, strep throat, vaccines, and others.
The list of FDA approved drugs for pediatrics and neonatology appears below. Click any link to view the full drug information.
Number Of Pediatrics Drugs: 87
For the treatment of growth failure in pediatrics
For the treatment of systemic juvenile idiopathic arthritis
Treatment for attention-deficit/hyperactivity disorder
Once-daily medication for the treatment of attention deficit/hyperactivity disorder (ADHD)
For the treatment of Mucopolysaccharidosis I (MPS I) in subjects aged 5 to 65
For the treatment Diarrhea caused by Cryptosporidium and Giardia in children.
For the treatment of impetigo due to Staphylococcus aureus or Streptococcus pyogenes
For the maintenance treatment of asthma as prophylactic therapy in adults and adolescents
Treatment (antibiotic) for common bacteria
Genetic test for birth defects
Treatment for ethylene glycol poisoning
For the treatment of HIV
For the treatment of seizures associated with Lennox-Gastaut syndrome in pediatrics and adults
For the treatment of abdominal or facial attacks of hereditary angioedema
Treatment of fever and minor aches and pains
For the treatment of angioedema attacks in adolescents/adults with Hereditary Angioedema
Treatment for children with seasonal allergies
For gout flares and familial Mediterranean fever
Treatment for respiratory distress syndrome in premature infants.
For the treatment of chronic severe drooling in pediatrics with neurologic conditions
Treatment for Attention Deficit Disorder
For the treatment of chronic obstructive pulmonary disease
Pediatric vaccine for immunization against diptheria, tetanus and pertussis
Treatment for nocturnal enuresis
For the treatment of atopic dermatitis
For the treatment of asthma
For the treatmenr of mucopolysaccharidosis II (Hunter Syndrome)
Treatment of asthma in patients four and older
Treatment for otitis media
Preservative free, pediatric dose, influenza virus vaccine for the immunization of infants
For the treatment of attention deficit hyperactivity disorder (ADHD)
For the treatment of growth failure in children who were born small for gestational age (SGA)
Treatment for pedicatric growth disorder
Treatment for hepatitis A
For the prevention of invasive disease caused by Haemophilus influenzae type b.
For the treatment of Cryopyrin-Associated Periodic Syndromes
Treatment for diphtheria, tetanus and pertussis (whooping cough) in infants and children
For the prevention and treatment of Respiratory Distress Syndrome (RDS) in premature infants
For the treatment of ADHD in children and adolescents
For the treatment of attention deficit hyperactivity disorder
For the treatment of hemophilia A
For adults and children w/Type 1 diabetes, or adults w/Type 2 diabetes requiring basal insulin to control hyperglycemia
For the treatment of type I and type II diabetes mellitus in adults and pediatrics
Treatment for intra-abdominal infections and bacterial meningitis
Oral capsules for the treatment of attention deficit hyperactivity disorder
For the treatment of tonsillitis and/or pharyngitis secondary to Streptococcus pyogenes in adults and pediatrics
For the treatment of Pompe disease (glycogen storage disease type II)
Treatment of nasal symptoms of seasonal allergic rhinitis in children Aged 6-11
Over-the-counter nasal spray for treatment of all nasal allergy symptoms
For the treatment of partial seizures in pediatric patients three years of age and older
Treatment of children who have growth failure
Treatment for HIV infection
Treatment against various bacterias
For the adjunctive treatment of seizures associated with Lennox-Gastaut syndrome
For the treatment of Juvenile Idiopathic Arthritis
Capsules for the treatment of hereditary tyrosinemia type I
For the treatment of seasonal allergic rhinitis
For the prevention of diphtheria, tetanus, pertussi, polio and hepatitis B in children 6 weeks to 7 years old.
Treatment for cystic fibrosis
For the treatment of asthma
Treatment for the prevention of respiratory syncytial virus disease
Oral capsules for the treatment Attention-Deficit/Hyperactivity Disorder (ADHD)
Treatment for pediatric otitis media
Treatment for acute otitis media
For the prevention of rotavirus gastroenteritis caused by G1 and non-G1 types (G3, G4, and G9) in pediatrics
For the treatment of infantile spasms and complex partial seizures
Treatment for asthma
For the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children, adolescents and adults.
For the treatment of central precocious puberty
Treatment for young children with epilepsy
Treatment for mild-to-moderate bronchial asthma
Treatment for asthma
Treatment for septicemia
Treatment for wide range of infections in children
Treatment for cystic fibrosis
Treatment for epilepsy in pediatric patients
Approved for use as adjunctive therapy in the treatment of partial seizures in children (monotherapy for adults)
Treatment for whooping cough
For the treatment of acne vulgaris
For the treatment of seasonal and perennial allergic rhinitis
Treatment for sedating children who must undergo painful surgery
Treatment for HIV infection in adults and children
Treatment for inflammation of the cornea in children due to herpes simplex virus
For the treatment of Attention-Deficit/Hyperactivity Disorder
For the treatment of seasonal and perennial allergic rhinitis and urticaria
Treatment for infants and children infected with HIV
Treatment of panic disorder in children ages 6-17
FDA Approved Pediatrics Drugs Listings:
The rules of principle for evaluating MediLexicon's FDA pediatrics drugs listings adhere to the FDA definitions of a new drug approval or a new molecular entity, and the Tufts Center for the Study of Drug Development.
MediLexicon's FDA Approved Drugs Listings include:
New Molecular Entities (NME): these NME's are described as a medication containing an active substance that have never previously approved in the US for marketing in any manner, shape or form (as defined by the FDA). In addition to this, there is also the inclusion of some FDA's Center for Drug Evaluation and Research (CDER) approved recombinant proteins and biologics.
MediLexicon's FDA Approved Drugs Listings do NOT include:
Over-the-counter products, diagnostic agents, generics, most vaccines, medical devices, biologic compounds (not approved by CDER), as well as new indications and new administrations of previously-approved compounds and new dosages.
The pediatrics drugs information used in this section is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.



